Integrating Guidelines, Experience and Clinical Judgement in the Management of Thyroid Cancer

This online enduring material is a reproduction of the live session that was held at the 2017 AACE Annual Meeting in Austin, TX.

Target Audience

All physicians and allied health professionals interested in the study, diagnosis, and treatment of endocrine-related diseases.

Learning Objectives

  • Describe major changes in the 2015 ATA Guidelines on Thyroid Nodules and Differentiated Thyroid Cancer and how these should be applied in clinical practice
  • Implement the latest ultrasound risk stratification model in choosing which patients with thyroid nodules should undergo fine‐needle aspiration biopsy and which patients can be monitored
  • Apply risk stratification and response to therapy as modifiers of recurrence risk to personalize long‐term management and monitoring in patients with DTC
  • Understand how the new ATA guidelines change perioperative (pre‐ and post‐op) management
  • Understand how the new ATA guidelines change surgical strategies
  • To be familiar with the pivotal studies that have served as the underpinnings for these surgical management recommendations
  • Review clinical characteristics of resistant thyroid cancer
  • Review expected clinical outcomes in resistant thyroid cancer
  • Review treatment options in resistant thyroid cancer
  • Compare the 2015 ATA guidelines with the previously published guidelines
  • Understand the 2015 guidelines
  • Ensure that the 2015 guidelines are put in the proper clinical context
Additional information
Faculty Disclosures58.65 KB
Available for MOC Points?: 
Practice Area: 
Course summary
Available credit: 
  • 2.75 AMA
  • 2.75 Attendance
Course opens: 
Course expires: 

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The American Association of Clinical Endocrinologists (AACE) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill or performance. As part of AACE’s duty to you as a learner, you have the right to expect that your continuing medical education experience with AACE includes:


  • Promotes improvements or quality in healthcare;
  • Is Valid, reliable and accurate;
  • Offers balanced presentations that are free of commercial bias for or against a product/service;
  • Is vetted through a process that resolves any conflicts of interest of planners, teachers or authors;
  • Is driven and based on learning needs, not commercial interests;
  • Addresses the stated objectives or purpose; and
  • Is evaluated for its effectiveness in meeting the identified educational need.


  • Supports learners’ ability to meet their individual needs;
  • Respects and attends to any special needs of the learners;
  • Respects the diversity of groups of learners; and
  • Is free of promotional, commercial and/or sales activities.


  • Relevant financial relationships planners, teachers and authors have with commercial interests related to the content of the activity; and
  • Commercial support (funding or in-kind resources) of the activity.

Available Credit

  • 2.75 AMA
  • 2.75 Attendance

Accreditation Period

Course opens: 
Course expires: 


Please login or register to take this course.